-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Head to Head Survey: Advanced Biomedical Technologies (OTCMKTS:ABMT) Versus Vicarious Surgical (NYSE:RBOT)
Head to Head Survey: Advanced Biomedical Technologies (OTCMKTS:ABMT) Versus Vicarious Surgical (NYSE:RBOT)
Vicarious Surgical (NYSE:RBOT – Get Rating) and Advanced Biomedical Technologies (OTCMKTS:ABMT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations.
Profitability
This table compares Vicarious Surgical and Advanced Biomedical Technologies' net margins, return on equity and return on assets.
Get Vicarious Surgical alerts:Net Margins | Return on Equity | Return on Assets | |
Vicarious Surgical | N/A | -68.56% | -45.62% |
Advanced Biomedical Technologies | N/A | N/A | N/A |
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Vicarious Surgical and Advanced Biomedical Technologies, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Vicarious Surgical | 0 | 1 | 2 | 0 | 2.67 |
Advanced Biomedical Technologies | 0 | 0 | 0 | 0 | N/A |
Volatility and Risk
Vicarious Surgical has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, Advanced Biomedical Technologies has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500.
Valuation & Earnings
This table compares Vicarious Surgical and Advanced Biomedical Technologies' top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Vicarious Surgical | N/A | N/A | -$35.21 million | $0.71 | 2.65 |
Advanced Biomedical Technologies | $120,000.00 | 29.54 | -$670,000.00 | N/A | N/A |
Advanced Biomedical Technologies has higher revenue and earnings than Vicarious Surgical.
Insider & Institutional Ownership
51.8% of Vicarious Surgical shares are held by institutional investors. 52.5% of Vicarious Surgical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Vicarious Surgical beats Advanced Biomedical Technologies on 5 of the 9 factors compared between the two stocks.
About Vicarious Surgical
(Get Rating)
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
About Advanced Biomedical Technologies
(Get Rating)
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
Vicarious Surgical (NYSE:RBOT – Get Rating) and Advanced Biomedical Technologies (OTCMKTS:ABMT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations.
Surgical(NYSE:RBOT-GET Rating)和Advanced Biomedical Technologies(OTCMKTS:ABMT-GET Rating)都是小盘医疗公司,但哪一家是优势业务?我们将根据两家公司的风险、盈利能力、股息、机构所有权、估值、收益和分析师的建议来比较它们的实力。
Profitability
盈利能力
This table compares Vicarious Surgical and Advanced Biomedical Technologies' net margins, return on equity and return on assets.
此表比较了替代外科技术公司和先进生物医疗技术公司的净利润率、股本回报率和资产回报率。
Net Margins | Return on Equity | Return on Assets | |
Vicarious Surgical | N/A | -68.56% | -45.62% |
Advanced Biomedical Technologies | N/A | N/A | N/A |
净利润率 | 股本回报率 | 资产回报率 | |
代替性外科 | 不适用 | -68.56% | -45.62% |
先进生物医学技术 | 不适用 | 不适用 | 不适用 |
Analyst Recommendations
分析师建议
This is a breakdown of recent ratings and price targets for Vicarious Surgical and Advanced Biomedical Technologies, as provided by MarketBeat.com.
这是由MarketBeat.com提供的替代外科和先进生物医学技术最近的评级和目标价细目。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Vicarious Surgical | 0 | 1 | 2 | 0 | 2.67 |
Advanced Biomedical Technologies | 0 | 0 | 0 | 0 | N/A |
销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
代替性外科 | 0 | 1 | 2 | 0 | 2.67 |
先进生物医学技术 | 0 | 0 | 0 | 0 | 不适用 |
Volatility and Risk
波动性和风险
Vicarious Surgical has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, Advanced Biomedical Technologies has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500.
该公司的贝塔系数为0.81,表明其股价的波动性比标准普尔500指数低19%。相比之下,Advanced Biomedical Technologies的贝塔系数为0.61,这表明其股价的波动性比标准普尔500指数低39%。
Valuation & Earnings
估值与收益
This table compares Vicarious Surgical and Advanced Biomedical Technologies' top-line revenue, earnings per share (EPS) and valuation.
此表比较了Surgical和Advanced Biomedical Technologies的营收、每股收益(EPS)和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Vicarious Surgical | N/A | N/A | -$35.21 million | $0.71 | 2.65 |
Advanced Biomedical Technologies | $120,000.00 | 29.54 | -$670,000.00 | N/A | N/A |
总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
代替性外科 | 不适用 | 不适用 | -3,521万元 | $0.71 | 2.65 |
先进生物医学技术 | $120,000.00 | 29.54 | -$670,000.00 | 不适用 | 不适用 |
Advanced Biomedical Technologies has higher revenue and earnings than Vicarious Surgical.
先进生物医学技术公司的收入和收益比替代外科公司更高。
Insider & Institutional Ownership
内部人与机构所有权
51.8% of Vicarious Surgical shares are held by institutional investors. 52.5% of Vicarious Surgical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
代理外科公司51.8%的股份由机构投资者持有。该公司52.5%的股份由公司内部人士持有。强大的机构持股表明,大型基金管理公司、对冲基金和捐赠基金相信,一只股票有望实现长期增长。
Summary
摘要
Vicarious Surgical beats Advanced Biomedical Technologies on 5 of the 9 factors compared between the two stocks.
在两只股票之间进行比较的9个因素中,有5个超过了先进生物医疗技术公司。
About Vicarious Surgical
关于代谢性外科
(Get Rating)
(获取评级)
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
该公司是美国的一家机器人技术公司。该公司专注于开发和商业化维多利亚系统,这是一种单切口手术机器人,可以虚拟地将外科医生运送到患者体内进行微创手术。该公司成立于2014年,总部设在马萨诸塞州的沃尔瑟姆。
About Advanced Biomedical Technologies
关于先进的生物医学技术
(Get Rating)
(获取评级)
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.
高级生物医学技术公司是一家处于发展阶段的公司,设计、开发、制造和销售生物材料内固定设备。它提供聚合物骨接合设备,如外科螺丝、捆绑钢丝、棒和相关医疗设备,用于治疗骨科创伤、与运动相关的医疗、软骨修复和相关治疗,以及重建牙科程序。该公司前身为Geostar矿业公司,并于2009年3月更名为Advanced Biomedical Technologies,Inc.。先进生物医学技术公司成立于2002年,总部设在纽约。
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
接受《替代外科日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯,接收对替代外科及相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧